|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2009-7-27
|
|
pubmed:abstractText |
This phase II study assessed the clinical activity of neoadjuvant therapy with carboplatin, gemcitabine, and thalidomide in patients with stage IIB to IIIA non-small cell lung cancer (NSCLC). A secondary goal was to assay a panel of candidate serum biomarkers before and after neoadjuvant therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
969-75
|
|
pubmed:meshHeading |
pubmed-meshheading:19633472-Adult,
pubmed-meshheading:19633472-Aged,
pubmed-meshheading:19633472-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19633472-Carboplatin,
pubmed-meshheading:19633472-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:19633472-Chemotherapy, Adjuvant,
pubmed-meshheading:19633472-Combined Modality Therapy,
pubmed-meshheading:19633472-Deoxycytidine,
pubmed-meshheading:19633472-Female,
pubmed-meshheading:19633472-Humans,
pubmed-meshheading:19633472-Lung Neoplasms,
pubmed-meshheading:19633472-Male,
pubmed-meshheading:19633472-Middle Aged,
pubmed-meshheading:19633472-Neoadjuvant Therapy,
pubmed-meshheading:19633472-Neoplasm Staging,
pubmed-meshheading:19633472-Pneumonectomy,
pubmed-meshheading:19633472-Prognosis,
pubmed-meshheading:19633472-Prospective Studies,
pubmed-meshheading:19633472-Survival Rate,
pubmed-meshheading:19633472-Thalidomide,
pubmed-meshheading:19633472-Treatment Outcome,
pubmed-meshheading:19633472-Tumor Markers, Biological
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Phase II trial of neoadjuvant therapy with carboplatin, gemcitabine plus thalidomide for stages IIB and III non-small cell lung cancer.
|
|
pubmed:affiliation |
Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota 55455, USA. dudek002@umn.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
